Bank of Nova Scotia »

Karuna Therapeutics Ord shares owned by Bank of Nova Scotia

Quarter-by-quarter ownership of Karuna Therapeutics Ord shares owned by Bank of Nova Scotia from 13F filings

Historical chart of Bank of Nova Scotia investment in Karuna Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Karuna Therapeutics Ord held by Bank of Nova Scotia consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Karuna Therapeutics Ord by Bank of Nova Scotia

Quarter filed Position value Share count Share price at filing
2023-12-31 $38M 120k 316.50

More positions owned by Bank of Nova Scotia

Rbc Cad (RY)
Apple (AAPL)
Microsoft Corporation (MSFT)
Toronto Dominion Bk Ont Com New (TD)
NVIDIA Corporation (NVDA)
Bank Of Montreal Cadcom (BMO)
Cibc Cad (CM)
Tc Energy Corp (TRP)
Enbridge (ENB)
Broadcom (AVGO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Canadian Natural Resources (CNQ)
Brookfield Corp Cl A Ltd Vt Sh (BN)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Bank of Nova Scotia

Top funds holding Karuna Therapeutics Ord

Vanguard Group
T. Rowe Price Associates
Pentwater Capital Management
Wellington Management Company
UBS Group
Alliancebernstein
Norges Bank Investment Management
Balyasny Asset Management
First Light Asset Management
Citadel Advisors
Boxer Capital
Charles Schwab Investment Management
Alpine Associates Management
Avidity Partners Management
Goldman Sachs Group

View all funds holding Karuna Therapeutics Ord